In 2023, Christal M.M. Mickle earned $2.05M in total compensation at Zevra Therapeutics, Inc., including $512.00K salary, $173.26K bonus and $1.35M in stock.
Compensation History
Annual executive compensation data for Christal M.M. Mickle, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$2.05M
Salary
$512.00K
Bonus
$173.26K
Other
$13.60K
Salary
$512.00KBoard Justification
The compensation philosophy aims to attract, retain, and motivate talented executives, aligning their interests with those of stockholders through performance-based incentives.
Bonus
$173.26KBoard Justification
Annual performance-based bonus opportunity based on achievement of corporate performance objectives for the year 2023.
Other Compensation
$13.60KBoard Justification
Includes 401(k) employer matching contributions and premiums paid for life insurance policies.
Restricted Stock
Board Justification
Stock options granted in 2023 that vested during the year.
Performance Metrics
Performance metrics for the bonus included the achievement of specified development, regulatory, and financial milestones.
Christal M.M. Mickle
Founder and Ex-CEO of Zevra Therapeutics, Inc.
Education
M.A. degree in Medicinal Chemistry from the University of Virginia; B.A. and B.S. degrees in Chemistry and Biochemistry from Virginia Polytechnic Institute and State University
Sector of Economy
Healthcare
Born
January 1, 1979 - 46 years ago
CEO of Zevra Therapeutics, Inc. for
0 years 4 months (Jun 2023 - Oct 2023)
Previous Experience
Senior Vice President, Operations and Product Development at Zevra Therapeutics, Inc.
Holdings
Track Christal M.M. Mickle's stock holdings and portfolio value over time.
Insider Trading
Christal M.M. Mickle's recent stock transactions, purchases, and sales filed with the SEC.
No insider trades found for this CEO.
Rivals
Compare Christal M.M. Mickle with competitor CEOs and industry peers.